Gouty Arthritis (Gout) — Pipeline Review, H2 2015

1
Gouty Arthritis (Gout) - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Gouty Arthritis (Gout)
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Gouty Arthritis
  (Gout) and enlists all their major and minor
  projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Gouty Arthritis (Gout) products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Gouty Arthritis (Gout) pipeline
  on the basis of target, MoA, route of
  administration and molecule type
• Read More At http//www.researchbeam.com/gouty-a
  rthritis-gout-pipeline-review-h2-2015-market

3


Table of Content
List of Figures Number of Products under
Development for Gouty Arthritis (Gout), H2 2015
11 Number of Products under Development for Gouty
Arthritis (Gout) - Comparative Analysis, H2 2015
12 Number of Products under Development by
Companies, H2 2015 13 Comparative Analysis by
Late Stage Development, H2 2015 16 Comparative
Analysis by Clinical Stage Development, H2 2015
17 Comparative Analysis by Early Stage Products,
H2 2015 18 Assessment by Monotherapy Products, H2
2015 42 Number of Products by Top 10 Targets, H2
2015 43 Number of Products by Stage and Top 10
Targets, H2 2015 43 Number of Products by Top 10
Mechanism of Actions, H2 2015 45 Number of
Products by Stage and Top 10 Mechanism of
Actions, H2 2015 45 Number of Products by Routes
of Administration, H2 2015 47 Number of Products
by Stage and Routes of Administration, H2 2015
47 Number of Products by Molecule Types, H2 2015
49 Number of Products by Stage and Molecule
Types, H2 2015 49
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Gouty Arthritis (Gout) Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Gouty Arthritis (Gout) pipeline
depth and focus of Indication therapeutics Develop
and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/gouty-arthritis-gout-p
ipeline-review-h2-2015-market/enquire-about-report

5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/gouty-arthritis-gout-p
ipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com